Several studies have demonstrated the importance of PPARGC1A in mitochondrial β-oxidation and oxidative stress in the pathogenesis of NAFLD [47,48]. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.